Tissue Engineering and New Biomaterials

Tissue engineering became one of the hot topics of medicine just after the review article by Langer and Vacanti in 1993 with title “Tissue Engineering,” and today tissue engineering is known to be a multidisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ [1]. The strategies of tissue engineering or in other words “regenerative medicine” require both relation and communication of cells with tissue by signaling pathways [1–3].

[1]  N. Peppas,et al.  Structure and Interactions in Covalently and Ionically Crosslinked Chitosan Hydrogels for Biomedical Applications , 2003 .

[2]  Yoshito Ikada,et al.  Challenges in tissue engineering , 2006, Journal of The Royal Society Interface.

[3]  G. Schultz,et al.  Interactions between extracellular matrix and growth factors in wound healing , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[4]  L. Robert.  Matrix biology: past, present and future. , 2001, Pathologie-biologie.

[5]  Kenneth M. Yamada,et al.  Dynamic cell-matrix interactions modulate microbial biofilm and tissue 3D microenvironments. , 2016, Current opinion in cell biology.

[6]  S. Neau,et al.  Lipase-catalyzed enantioselective esterification of flurbiprofen with n-butanol , 2000 .

[7]  B. Brown,et al.  The Role of the Host Immune Response in Tissue Engineering and Regenerative Medicine , 2014 .

[8]  J. Fisher,et al.  Signal Expression in Engineered Tissues , 2012 .

[9]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[10]  Kevin M. Shakesheff,et al.  Tissue engineering: strategies, stem cells and scaffolds , 2008, Journal of anatomy.

[11]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[12]  James M. Anderson,et al.  Macrophage fusion and multinucleated giant cells of inflammation. , 2011, Advances in experimental medicine and biology.

[13]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[14]  Ali Khademhosseini,et al.  3D biofabrication strategies for tissue engineering and regenerative medicine. , 2014, Annual review of biomedical engineering.

[15]  Hae-Won Kim,et al.  Strategies for osteochondral repair: Focus on scaffolds , 2014, Journal of tissue engineering.

[16]  M. Martins-Green,et al.  The Dynamics of Cell-ECM Interactions, with Implications for Tissue Engineering , 2014 .

[17]  A. Seifalian,et al.  Osteogenic potential of stem cells-seeded bioactive nanocomposite scaffolds: A comparative study between human mesenchymal stem cells derived from bone, umbilical cord Wharton's jelly, and adipose tissue. , 2018, Journal of biomedical materials research. Part B, Applied biomaterials.

[18]  J W Eaton,et al.  Molecular basis of biomaterial-mediated foreign body reactions. , 2001, Blood.

[19]  Antonios G. Mikos,et al.  Formation of highly porous biodegradable scaffolds for tissue engineering , 2000 .

[20]  A. Bolstad,et al.  Angiogenic and Immunomodulatory Properties of Endothelial and Mesenchymal Stem Cells , 2016, Tissue engineering. Part A.

[21]  K. Leong,et al.  Scaffolding in tissue engineering: general approaches and tissue-specific considerations , 2008, European Spine Journal.